Results 1 to 10 of about 13,403 (128)
A novel glycyrrhizin acid-coated stent reduces neointimal formation in a rabbit iliac artery model
Frontiers in Pharmacology, 2023 Introduction: Most drug-eluting stents (DESs) inhibit intimal hyperplasia but impair re-endothelialization. This study aimed to evaluate in vivo strut coverage and neointimal growth in a new glycyrrhizin acid (GA)-eluting stent.Methods: New Zealand White
Shuai Teng +6 more
doaj +1 more source
Frontiers in Cardiovascular Medicine, 2021 Background and Objectives: The second-generation drug-eluting stents have been used to treat chronic total occlusion lesion. However, there is limited evidence of the clinical outcomes that whether the second-generation drug-eluting stents is superior to
Xuan Qiao +5 more
doaj +1 more source
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021 Background Premature discontinuation of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention is related to higher short‐term risks of adverse outcomes. Whether these risks persist in the long‐term is uncertain. Methods and Results We
Scott Kinlay +11 more
doaj +1 more source
The role of optical coherence tomography guidance in scaffold versus stent optimization
The Egyptian Heart Journal, 2020 Background Optical coherence tomography showed a great ability to identify adverse features during percutaneous coronary intervention with drug-eluting stents and resulted in better clinical outcomes.
Arif A. Al Nooryani +4 more
doaj +1 more source
Mass Spectrometry Reviews, EarlyView., 2023 Abstract Biodegradable polymers have been getting more and more attention because of their contribution to the plastic pollution environmental issues and to move towards a circular economy. Nevertheless, biodegradable materials still exhibit various disadvantages restraining a widespread use in the market.
Paola Rizzarelli +2 more
wiley +1 more source
An Analysis of Cost-Effectiveness of Stents Used in the Treatment of Coronary Artery Disease
Balkan Medical Journal, 2019 Background: There is only limited information about the cost-effectiveness of drug-eluting stents compared with bare-metal stents in Turkey. Aims: To evaluate bare-metal and drug-eluting stents used in the treatment of coronary artery disease from the ...
Ferda Işıkçelik +2 more
doaj +1 more source
Outcomes of supraflex Sirolimus-eluting coronary stents
Current Medical Issues, 2022 Background: The development of a sirolimus-eluting coronary stent (SES) was a big step forward in interventional cardiology. SES has been demonstrated in large, randomized clinical studies to reduce angiographic restenosis and target vessel ...
Vishal Virendra Singh +2 more
doaj +1 more source
Biodegradable Cable-Tie Rapamycin-eluting Stents
Scientific Reports, 2017 “Cable-tie” type biodegradable stents with drug-eluting nanofiber were developed to treat rabbit denuded arteries in this study. Biodegradable stents were fabricated using poly-L-lactide film following being cut and rolled into a cable-tie type stent ...
Cheng-Hung Lee +11 more
doaj +1 more source
Arquivos Brasileiros de Cardiologia, 2009 Os stents farmacológicos representam um importante avanço na terapêutica da doença aterosclerótica coronariana. Recentemente tem sido descrita a fratura de stents farmacológicos, associada à reestenose e trombose.
Michel Pereira Cadore +3 more
doaj +1 more source
The stenting strategy of drug-eluting stents for coronary artery disease in patients on dialysis
SAGE Open Medicine, 2014 Background: Reports regarding the relationship between the length and diameter of implanted drug-eluting stents and clinical and angiographic outcomes in dialysis patients are limited.
Hiroshi Fujita +6 more
doaj +1 more source